**Core Concept**
Dobutamine is a synthetic catecholamine used as a medication to treat acute heart failure and cardiogenic shock. It works by increasing cardiac contractility, heart rate, and cardiac output through beta-1 and beta-2 adrenergic receptor stimulation. The pharmacokinetics of dobutamine is essential for understanding its clinical effects and potential side effects.

**Why the Correct Answer is Right**
The half-life of dobutamine is approximately 2 minutes. This short half-life allows for rapid titration of the medication to achieve the desired effect and minimizes the risk of accumulation and toxicity. Dobutamine is primarily metabolized by catechol-O-methyltransferase (COMT) in the liver, and its rapid elimination is mediated by the kidneys. The short half-life of dobutamine necessitates continuous intravenous infusion to maintain its therapeutic effects.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because the half-life of dobutamine is not significantly influenced by renal function. Although the kidneys play a role in the elimination of dobutamine, its short half-life is primarily a result of hepatic metabolism.

**Option B:** This option is incorrect because the half-life of dobutamine is not similar to that of epinephrine. Epinephrine has a half-life of approximately 2 minutes, but its effects are longer-lasting due to its alpha-adrenergic receptor stimulation and slower metabolism.

**Option C:** This option is incorrect because the half-life of dobutamine is not similar to that of isoproterenol. Isoproterenol has a half-life of approximately 2-4 minutes, but it has a different pharmacological profile and is not primarily used for the treatment of heart failure.

**Clinical Pearl / High-Yield Fact**
Remember that the short half-life of dobutamine necessitates continuous intravenous infusion to maintain its therapeutic effects. This is in contrast to medications with longer half-lives, which may be administered intermittently.

**Correct Answer: C. 2 minutes**